TGF-β1 DNA polymorphisms, protein levels, and blood pressure

Hypertension

Volumn 33, Issue 1 II, 1999, Pages 271-275

  Li, Baogui ^b   Khanna, Ashwani ^b   Sharma, Vijay ^b   Singh, Tejinder ^b   Suthanthiran, Manikkam ^b   August, Phyllis ^a  

^a Hypertension Division   (United States)

^b NONE

Author keywords

Gene polymorphism; Renal disease; Transforming growth factor 1

Indexed keywords

DNA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ALLELE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; SYSTOLIC BLOOD PRESSURE; AMINO ACID SUBSTITUTION; BLOOD; BLOOD PRESSURE; CHRONIC KIDNEY FAILURE; CODON; COHORT ANALYSIS; GENETIC POLYMORPHISM; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; POINT MUTATION; REFERENCE VALUE; REGRESSION ANALYSIS; SYSTOLE;

AMINO ACID SUBSTITUTION; BLOOD PRESSURE; CODON; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; REFERENCE VALUES; REGRESSION ANALYSIS; SYSTOLE; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032609711     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.33.1.271     Document Type: Article

References (22)

1. Roberts AM, Sporn MB. Transforming growth factor β. Adv Cancer Res. 1988;51:107-145.
2. Border WA, Nobel NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
3. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF, fibronectin, and collagen. Am J Physiol. 1992; 262:H1861-H1866.
4. Sarzani R, Brecher P, Chobanian AV. Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest. 1989;83: 1404-1408.
5. Ketteler M, Noble NA, Border WA. Increased expression of transforming growth factor-beta in renal disease. Curr Opin Nephrol Hypertens. 1994; 3:446-452.
6. Bottinger EP, Letterio JJ, Roberts AB. Biology of TGF-β in knockout and transgenic mouse models. Kidney Int. 1997;51:1255-1360.
7. Kurihara H, Yoshizumi M, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Hamaoki M, Kato H, Yazaki Y. Transforming growth factor β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun. 1989;159:1435-1440.
8. Border WA, Noble NA. Interactions of transforming growth factor-β and angiotensin II in renal fibrosis. Hypertension. 1998;3(part 2):181-188.
9. Cambien F. Ricard S. Troesch A, Mallet C, Generenaz L. Evans A, Arveiler D. Luc G, Ruidavets J-B. Poirer O. Polymorphisms of the transforming growth factor beta 1 gene in relation to myocardial infarction and blood pressure: the Etude Cas-Temoin de l'Infarctur du Myocarde (ECTIM.) Study. Hypertension. 1996;28:881-887.
10. El-Gamel A, Awad M, Sim E, Hasleton P, Yonan N, Egan J, Deiraniya A, Huthchinson IV. Transforming growth factor betal and lung allograft fibrosis. Eur J Cardiothorac Sur. 1998;13:424-430.
11. Khanna A, Li B, Stenzel KH, Suthanthiran M. Regulation of new DNA synthesis in mammalian cells by cyclosporine: demonstration of a transforming growth factor β dependent mechanism of inhibition of cell growth. Transplantation. 1994;57:577-582.
12. Newton CR, Graham A, Heptinstall, LE, Powell SJ, Summers C, Kalsheker N, Smith JC, and Markham AF. Analysis of any point mutation in DNA: the amplification refractory mutation system (ARMS). Nucleic Acids Res. 1989;17:2503-2516.
13. Little S. Amplification-refracting mutation system (ARMS) analysis of point mutations. In: Dracopoli NC, Haines JL, Korf BR, et al. Current Protocols in Human Genetics, Unit 9,8. New York, NY: John Wiley and Sons Inc; 1995:9.8.1-9.8.12.
14. 1 hyperexpression in African American end-stage renal disease patients. Kidney Int. 1998;53:639-644.
15. Agrotis A, Saltis J, Bobik A. Transforming growth factor-β1 gene activation and growth of smooth muscle from hypertensive rats. Hypertension. 1994;23:593-599.
16. Nabel EG, Shum L, Pompili VJ, Yang ZY, San H, Shu HB, Liptay S, Gold L, Gordon D, Derynck R, Nabel GJ. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A. 1993;90:10759-10763.
17. Porreca E, Di Febbo C, Mincione G, Reale M, Baccante G, Domenica Gugliemli M, Cuccurullo F, Colletta G. Increased transforming growth factor-β production and gene expression by peripheral blood monocytes of hypertensive patients. Hypertension. 1997;30(part 1):134-139.
18. Tamaki K, Okuda S, Nakayama M, Yanagida T, Fujishima M. Transforming growth factor-beta 1 in hypertensive renal injury in Dahl salt-sensitive rats. J Am Soc Nephrol. 1996;7:2578-2589.
19. Antonipillai I, Hoang Le T, Soceneantu L, Horton R. Transforming growth factor β is a renin secretagogue at picomolar concentrations Am J Physiol. 1993;265:F537-F541.
20. Ray PE, McCune BK, Greary KM, Carey RM, Klotman PE, Gomez RA. Modulation of renin release and renal vascular smooth muscle cell contractility by TGF-β2. Contrib Nephrol. 1996;118:238-248.
21. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997;94:3195-3199.
22. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogen. 1997;24:1-8.